🎉 M&A multiples are live!
Check it out!

Lifecore Biomedical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Lifecore Biomedical and similar public comparables like Syngene International, Dishman Carbogen Amics, and Biocon.

Lifecore Biomedical Overview

About Lifecore Biomedical

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.


Founded

1986

HQ

United States of America
Employees

484

Website

lifecore.com

Financials

LTM Revenue $128M

LTM EBITDA $19.7M

EV

$353M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Lifecore Biomedical Financials

Lifecore Biomedical has a last 12-month revenue of $128M and a last 12-month EBITDA of $19.7M.

In the most recent fiscal year, Lifecore Biomedical achieved revenue of $128M and an EBITDA of $36.5M.

Lifecore Biomedical expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Lifecore Biomedical valuation multiples based on analyst estimates

Lifecore Biomedical P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $103M $128M XXX XXX XXX
Gross Profit $50.4M $28.0M XXX XXX XXX
Gross Margin 49% 22% XXX XXX XXX
EBITDA -$33.0M $36.5M XXX XXX XXX
EBITDA Margin -32% 28% XXX XXX XXX
Net Profit -$97.4M -$99.6M XXX XXX XXX
Net Margin -94% -78% XXX XXX XXX
Net Debt $137M $82.6M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Lifecore Biomedical Stock Performance

As of April 15, 2025, Lifecore Biomedical's stock price is $6.

Lifecore Biomedical has current market cap of $228M, and EV of $353M.

See Lifecore Biomedical trading valuation data

Lifecore Biomedical Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$353M $228M XXX XXX XXX XXX $-1.12

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Lifecore Biomedical Valuation Multiples

As of April 15, 2025, Lifecore Biomedical has market cap of $228M and EV of $353M.

Lifecore Biomedical's trades at 2.8x LTM EV/Revenue multiple, and 18.0x LTM EBITDA.

Analysts estimate Lifecore Biomedical's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Lifecore Biomedical and 10K+ public comps

Lifecore Biomedical Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $353M XXX XXX XXX
EV/Revenue 2.8x XXX XXX XXX
EV/EBITDA 13.3x XXX XXX XXX
P/E -10.5x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Lifecore Biomedical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Lifecore Biomedical Valuation Multiples

Lifecore Biomedical's NTM/LTM revenue growth is 3%

Lifecore Biomedical's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Lifecore Biomedical's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Lifecore Biomedical's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Lifecore Biomedical and other 10K+ public comps

Lifecore Biomedical Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 24% XXX XXX XXX XXX
EBITDA Margin 21% XXX XXX XXX XXX
EBITDA Growth -211% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 24% XXX XXX XXX XXX
Revenue per Employee $0.3M XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue 7% XXX XXX XXX XXX
Opex to Revenue 38% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Lifecore Biomedical Public Comps

See public comps and valuation multiples for Contract Research & Manufacturing comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Jubilant Pharmova XXX XXX XXX XXX XXX XXX
Biocon XXX XXX XXX XXX XXX XXX
Syngene International XXX XXX XXX XXX XXX XXX
Dishman Carbogen Amics XXX XXX XXX XXX XXX XXX
Suven Pharma XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Lifecore Biomedical M&A and Investment Activity

Lifecore Biomedical acquired  XXX companies to date.

Last acquisition by Lifecore Biomedical was  XXXXXXXX, XXXXX XXXXX XXXXXX . Lifecore Biomedical acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Lifecore Biomedical

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Lifecore Biomedical

When was Lifecore Biomedical founded? Lifecore Biomedical was founded in 1986.
Where is Lifecore Biomedical headquartered? Lifecore Biomedical is headquartered in United States of America.
How many employees does Lifecore Biomedical have? As of today, Lifecore Biomedical has 484 employees.
Who is the CEO of Lifecore Biomedical? Lifecore Biomedical's CEO is Mr. Paul Josephs.
Is Lifecore Biomedical publicy listed? Yes, Lifecore Biomedical is a public company listed on NAS.
What is the stock symbol of Lifecore Biomedical? Lifecore Biomedical trades under LFCR ticker.
When did Lifecore Biomedical go public? Lifecore Biomedical went public in 1996.
Who are competitors of Lifecore Biomedical? Similar companies to Lifecore Biomedical include e.g. Jubilant Pharmova, Biocon, Syngene International, Dishman Carbogen Amics.
What is the current market cap of Lifecore Biomedical? Lifecore Biomedical's current market cap is $228M
What is the current revenue of Lifecore Biomedical? Lifecore Biomedical's last 12-month revenue is $128M.
What is the current EBITDA of Lifecore Biomedical? Lifecore Biomedical's last 12-month EBITDA is $19.7M.
What is the current EV/Revenue multiple of Lifecore Biomedical? Current revenue multiple of Lifecore Biomedical is 2.8x.
What is the current EV/EBITDA multiple of Lifecore Biomedical? Current EBITDA multiple of Lifecore Biomedical is 18.0x.
What is the current revenue growth of Lifecore Biomedical? Lifecore Biomedical revenue growth between 2023 and 2024 was 24%.
Is Lifecore Biomedical profitable? Yes, Lifecore Biomedical is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.